Total Payments
$117,734
2024 Payments
$20.27
Companies
22
Transactions
251
Medicare Patients
348
Medicare Billing
$30,972
Payment Breakdown by Category
Other$81,045 (68.8%)
Travel$17,755 (15.1%)
Consulting$10,450 (8.9%)
Food & Beverage$8,485 (7.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $77,045 | 30 | 65.4% |
| Travel and Lodging | $17,755 | 40 | 15.1% |
| Consulting Fee | $10,450 | 4 | 8.9% |
| Food and Beverage | $8,485 | 176 | 7.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,000 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $41,818 | 66 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $27,918 | 46 | $0 (2018) |
| AbbVie, Inc. | $21,908 | 61 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $19,636 | 26 | $0 (2018) |
| Shionogi Inc | $5,206 | 11 | $0 (2019) |
| Celltrion, Inc. | $307.22 | 2 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $240.83 | 10 | $0 (2024) |
| Sirtex Medical Inc | $107.78 | 1 | $0 (2017) |
| Romark Laboratories, LC | $86.28 | 2 | $0 (2017) |
| Amgen Inc. | $71.88 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.27 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($20.27) |
| 2022 | $45.29 | 1 | Theratechnologies Inc. ($45.29) |
| 2020 | $126.81 | 2 | Celltrion, Inc. ($91.84) |
| 2019 | $6,042 | 29 | Shionogi Inc ($5,185) |
| 2018 | $20,072 | 57 | Synergy Pharmaceuticals Inc ($10,898) |
| 2017 | $91,427 | 161 | Gilead Sciences Inc ($36,696) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Gastroenterology | ||||||
| 05/21/2022 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $45.29 | General |
| Category: HIV | ||||||
| 03/28/2020 | Merit Medical Systems Inc | Elation Balloon Dilator (Device), BIG60 Inflation device, EndoMAXX Stent and Delivery System | Food and Beverage | Cash or cash equivalent | $34.97 | General |
| Category: Endoscopy | ||||||
| 02/19/2020 | Celltrion, Inc. | — | Food and Beverage | In-kind items and services | $91.84 | General |
| 12/09/2019 | Celltrion, Inc. | — | Food and Beverage | Cash or cash equivalent | $215.38 | General |
| 11/11/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $61.63 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/10/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $107.71 | General |
| 11/04/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $126.50 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/27/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $48.77 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/17/2019 | Shionogi Inc | Mulpleta (Drug) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/17/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/11/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 08/13/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2019 | Shionogi Inc | Mulpleta (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 06/18/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Virology | ||||||
| 06/06/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 06/03/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $120.16 | General |
| 05/02/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 04/13/2019 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: HCV | ||||||
| 04/12/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 04/11/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $115.54 | General |
| 04/05/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: Virology | ||||||
| 03/27/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 158 | 186 | $40,501 | $12,946 |
| 2021 | 5 | 92 | 108 | $24,838 | $7,972 |
| 2020 | 5 | 98 | 111 | $18,559 | $10,054 |
Total Patients
348
Total Services
405
Medicare Billing
$30,972
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 63 | 64 | $14,272 | $5,041 | 35.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 43 | $6,579 | $2,441 | 37.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $9,558 | $1,764 | 18.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 17 | $3,740 | $1,393 | 37.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 12 | $3,600 | $1,306 | 36.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 24 | 32 | $2,752 | $1,001 | 36.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 27 | 29 | $8,700 | $3,230 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 25 | $3,825 | $1,467 | 38.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 17 | $3,791 | $1,418 | 37.4% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 12 | $6,372 | $1,074 | 16.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 18 | 25 | $2,150 | $783.25 | 36.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $4,365 | $2,344 | 53.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 22 | $4,356 | $2,281 | 52.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 28 | 28 | $4,088 | $2,249 | 55.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 22 | $3,278 | $1,808 | 55.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 24 | $2,472 | $1,373 | 55.5% |
About Dr. Patrick Basu, M.D
Dr. Patrick Basu, M.D is a Gastroenterology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053396572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Basu, M.D has received a total of $117,734 in payments from pharmaceutical and medical device companies, with $20.27 received in 2024. These payments were reported across 251 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($77,045).
As a Medicare-enrolled provider, Basu has provided services to 348 Medicare beneficiaries, totaling 405 services with total Medicare billing of $30,972. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Transplant Hepatology
- Location Orlando, FL
- Active Since 12/07/2005
- Last Updated 11/06/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053396572
Products in Payments
- Trulance (Drug) $27,918
- ZEPATIER (Drug) $19,568
- Epclusa (Drug) $17,917
- Mavyret (Drug) $13,853
- Vemlidy (Drug) $10,603
- Viekira (Drug) $7,557
- Vosevi (Drug) $5,268
- Mulpleta (Drug) $5,185
- Venclexta (Drug) $121.77
- XIFAXAN (Drug) $110.02
- SIR-Spheres Microspheres (Device) $107.78
- XIFIXAN (Drug) $103.57
- Alinia Tablets 500mg 30 count bottle (Drug) $86.28
- Creon (Drug) $83.73
- Humira (Biological) $68.55
- Repatha (Biological) $54.43
- INJECTAFER (Drug) $46.47
- EGRIFTA (Drug) $45.29
- Elation Balloon Dilator (Device) $34.97
- Sucraid (Drug) $34.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Orlando
Dr. Samuel Giday, M.d, M.D
Gastroenterology — Payments: $2.6M
Gastroenterology $2.6M
Jennifer Seminerio-Diehl, Md, MD
Gastroenterology — Payments: $814,283
Gastroenterology $814,283
Dr. Robert Hawes, Md, MD
Gastroenterology — Payments: $593,475
Gastroenterology $593,475
Muhammad Hasan, Md, MD
Gastroenterology — Payments: $261,176
Gastroenterology $261,176
Dr. Kenneth Feuer, Md, MD
Gastroenterology — Payments: $142,471
Gastroenterology $142,471
Dr. Natalie Cosgrove, Md, MD
Gastroenterology — Payments: $132,710
Gastroenterology $132,710